tiprankstipranks
Advertisement
Advertisement

Dyne Therapeutics 24.2M share Spot Secondary priced at $8.25

The deal range was $8.25-$9.00. Morgan Stanley, Jefferies, Stifel and Guggenheim acted as joint book running managers for the offering.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1